Risk-based monitoring is changing clinical development. Data generated from labs can account for 80% of data at submission. Understand the value being achieved by integrating critical data from labs into the RBM process, including:
By integrating lab data into risk-based monitoring, additional efficiencies and productivity would be achieved as we collaborate across the monitoring/lab interface, enabling streamlined data transfer and limiting hand-offs.
By attending this webinar you will:
Director, Clinical Development Productivity and Quality
Meredith M. Bell MSHS CRA, CSSGB
Associate Director Clinical Systems